{"id":"NCT00333814","sponsor":"Allergan","briefTitle":"A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis","officialTitle":null,"status":"COMPLETED","phase":"PHASE2","dates":{"start":"2006-05","primaryCompletion":"2008-12","completion":"2009-04","firstPosted":"2006-06-06","resultsPosted":"2011-04-14","lastUpdate":"2011-04-14"},"enrollment":229,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Intermediate Uveitis","Posterior Uveitis"],"interventions":[{"type":"DRUG","name":"Dexamethasone","otherNames":["Posurdex®"]},{"type":"DRUG","name":"dexamethasone","otherNames":["Posurdex®"]},{"type":"DRUG","name":"Sham injection","otherNames":[]}],"arms":[{"label":"1","type":"ACTIVE_COMPARATOR"},{"label":"2","type":"ACTIVE_COMPARATOR"},{"label":"3","type":"SHAM_COMPARATOR"}],"summary":"This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of non-infectious intermediate or posterior uveitis.","primaryOutcome":{"measure":"Percentage of Patients With Vitreous Haze (Ocular Inflammation) Score of Zero","timeFrame":"Week 8","effectByArm":[{"arm":"Dexamethasone 350 µg","deltaMin":35.5,"sd":null},{"arm":"Dexamethasone 700 µg","deltaMin":46.8,"sd":null},{"arm":"Sham","deltaMin":11.8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":2},"locations":{"siteCount":18,"countries":["United States","Australia","Austria","Brazil","Canada","Czechia","France","Germany","Greece","India","Israel","Poland","Portugal","South Africa","South Korea","Spain","Switzerland","United Kingdom"]},"refs":{"pmids":["23761087","23411886","21220619"],"seeAlso":["http://www.allerganclinicaltrials.com/inquiries/trialsubject.aspx"]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":74},"commonTop":["Conjunctival haemorrhage","Intraocular pressure increased","Eye Pain","Uveitis","Cataract"]}}